Dollar change -3.18
Percentage change -0.45	%

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT QUAL

Index	S&P 500	P/E	46.29	EPS (ttm)	15.08	Insider Own	10.34%	Shs Outstand	946.83M	Perf Week	9.89%
Market Cap	660.67B	Forward P/E	23.11	EPS next Y	30.21	Insider Trans	-0.92%	Shs Float	848.59M	Perf Month	-9.55%
Enterprise Value	697.11B	PEG	1.11	EPS next Q	6.31	Inst Own	73.59%	Short Float	0.85%	Perf Quarter	-7.83%
Income	13.80B	P/S	12.41	EPS this Y	74.59%	Inst Trans	-0.40%	Short Ratio	1.65	Perf Half Y	-17.32%
Sales	53.26B	P/B	36.17	EPS next Y	33.20%	ROA	15.97%	Short Interest	7.17M	Perf YTD	-9.58%
Book/sh	19.30	P/C	186.32	EPS next 5Y	41.57%	ROE	86.70%	52W High	972.53 -28.22%	Perf Year	-25.08%
Cash/sh	3.75	P/FCF	135.25	EPS past 3/5Y	24.14% 18.77%	ROIC	26.31%	52W Low	623.78 11.91%	Perf 3Y	131.78%
Dividend Est.	5.78 (0.83%)	EV/EBITDA	28.65	Sales past 3/5Y	16.73% 15.08%	Gross Margin	82.64%	Volatility	3.02% 3.06%	Perf 5Y	363.42%
Dividend TTM	5.80 (0.83%)	EV/Sales	13.09	EPS Y/Y TTM	88.21%	Oper. Margin	42.13%	ATR (14)	26.30	Perf 10Y	735.89%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.00	Sales Y/Y TTM	36.83%	Profit Margin	25.91%	RSI (14)	43.84	Recom	1.53
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.28	EPS Q/Q	91.71%	SMA20	-4.34%	Beta	0.46	Target Price	913.17
Payout	44.39%	Debt/Eq	2.18	Sales Q/Q	37.64%	SMA50	-8.48%	Rel Volume	1.15	Prev Close	701.23
Employees	47000	LT Debt/Eq	1.87	Earnings	Aug 07 BMO	SMA200	-11.91%	Avg Volume	4.34M	Price	698.05
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.70% 5.80%	Trades		Volume	4,982,037	Change	-0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500

Show Previous Ratings

Aug-18-25 11:14PM	Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery (Insider Monkey)
05:19PM	Eli Lilly Just Did What Almost No One Dares in 2025 (GuruFocus.com)
04:18PM	Eli Lilly Sells $6.75 Billion of Bonds in Seven-Part Deal (Bloomberg)
02:03PM	Should You Buy the Pop in Novo Nordisk Stock? (Barchart)
12:39PM	Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients (Fortune)
12:34PM	Loading…
12:34PM	Wegovy News Pushes Novo Nordisk Stock Higher (Barrons.com)
11:45AM	NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead? (Zacks)
11:39AM	Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings, at $499 Per Month. Why GoodRx Stock Spikes. (Barrons.com)
09:21AM	Company News for Aug 18, 2025 (Zacks)
09:13AM	Lilly Stock Down 5% This Month: Should You Buy the Dip? (Zacks)
09:07AM	Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers (Reuters)
09:00AM	GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month (Yahoo Finance)
09:00AM	GoodRx begins selling Novo Nordisk GLP-1s for cash price (Yahoo Finance)
09:00AM	Novo Nordisk Stock Is Jumping. The Good News Pushing Shares Higher. (Barrons.com)
08:35AM	Novo Nordisk, Eli Lilly, Soho House: Stocks (Yahoo Finance Video)
06:05AM	Loading…
06:05AM	Analysis: Wall Street sees new obesity pills as priced near Wegovy and Zepbound (Reuters)
05:26AM	FDA Approves Novo Nordisks Wegovy for Liver Disease (The Wall Street Journal)
03:58AM	Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market (Pharma Voice)
12:23AM	Eli Lilly and Company (LLY) Announces Results From LTE of Phase 3 TRAILBLAZER-ALZ 2 Study (Insider Monkey)
Aug-17-25 08:55AM	1 Beaten-Down Stock That Could Soar by the End of the Year (Motley Fool)
07:15AM	This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors (Motley Fool)
06:42AM	3 Fantastic Growth Stocks to Buy in August (Motley Fool)
02:13AM	JPMorgan Maintains 'Overweight' Rating on Eli Lilly and Company (LLY) With $1,100 PT (Insider Monkey)
12:54AM	Eli Lilly and Company (LLY) Releases Q2 2025 Results (Insider Monkey)
Aug-16-25 12:46PM	Jim Cramer Says Don't Quit Market When It's Frothy: 'Is Widespread Irrationality a Reason To Sell Down in Perfectly Rational Stocks? Absolutely Not' (Benzinga)
08:45AM	Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. (Motley Fool)
Aug-15-25 09:43PM	Cantor Fitzgerald Slashes PT on Eli Lilly and Company (LLY) to $825 From $975 (Insider Monkey)
05:31PM	Health Care Roundup: Market Talk (The Wall Street Journal)
03:16PM	Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst (Yahoo Finance)
02:55PM	Why Eli Lilly (LLY) Stock Is Up Today (StockStory)
01:54PM	Loading…
01:54PM	Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst (Benzinga)
12:25PM	Novo Nordisk Stock Could Benefit From Eli Lilly's Weight-Loss Price Hikes (Barrons.com)
10:14AM	UK patients rush to buy obesity jab ahead of 170% price rise (Financial Times)
09:48AM	Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US (CNN Business)
09:20AM	Veru Announces Novel Modified-Release Oral Formulation for Enobosarm (Zacks)
09:06AM	Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave? (Zacks)
08:48AM	Big Pharma Has a New Vision for Selling Drugs. It's Going to the Mattresses. (Barrons.com)
07:52AM	UK pharmacist says Eli Lillys Mounjaro price hike a shock (Pharmaceutical Technology)
06:40AM	Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More. (Barrons.com)
06:02AM	S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting (Barchart)
06:02AM	S&P Futures Muted With Focus on U.S. Retail Sales Data and Trump-Putin Meeting (Barchart)
02:53AM	Jim Cramer Says He is "Very Upset" With Eli Lilly (Insider Monkey)
Aug-14-25 07:00PM	Eli Lilly raises price of diabetes drug Mounjaro in UK ahead of Trump deadline (CNBC TV)
05:20PM	Guidance Watch: 2 Companies Bullishly Raising Forecasts (Zacks)
04:12PM	Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure Mounts (Investor's Business Daily)
03:54PM	Oracle, Eli Lilly, Terawulf: Trending Tickers (Yahoo Finance Video)
02:26PM	Eli Lilly Says It Will Raise European Prices of its Medicines as Trump Pushes for U.S. Price Cuts (Barrons.com)
02:20PM	Eli Lilly to Raise U.K. Price of Mounjaro for Out-of-Pocket Patients (The Wall Street Journal)
01:44PM	Eli Lilly and Company (LLY): "Wall Street Was Really Wrong," Says Jim Cramer (Insider Monkey)
01:31PM	Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal (Pharmaceutical Technology)
12:21PM	C3.ai downgrade, OracleAlphabet deal, Eli Lilly & Superluminal (Yahoo Finance Video)
11:46AM	Top Stock Movers Now: Tapestry, Deere, Eli Lilly, and More (Investopedia)
11:23AM	Lanier Law Firm Representing Health Choice Alliance in Litigation Alleging Eli Lilly Offered Kickbacks to Texas Health Care Providers (Business Wire)
11:07AM	Lilly Raises UK Obesity Shot Price as Trump Pressures Pharma (Bloomberg)
09:00AM	Goodpath Adds Self-Pay GLP-1 Option Through Integration with LillyDirect Pharmacy Provider GiftHealth (PR Newswire)
08:35AM	Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics (Zacks)
08:32AM	Eli Lilly raises UK price of weight loss drug Mounjaro by up to 170% (Financial Times)
08:15AM	Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines (Reuters)
08:04AM	Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity (PR Newswire)
06:30AM	4 trends among retail investors according to Robinhood's CIO (Yahoo Finance Video)
02:00AM	Vanguard Health Care Fund's Strategic Moves: Johnson & Johnson Takes Center Stage with 2. ... (GuruFocus.com)
01:36AM	5 Must-Read Analyst Questions From Eli Lilly's Q2 Earnings Call (StockStory)
Aug-13-25 03:37PM	Jim Cramer on Eli Lilly Stock: "It Just Got Pole-Axed, Laid to Waste" (Insider Monkey)
03:20PM	Why Eli Lilly Stock Popped Today (Motley Fool)
03:11PM	Eli Lilly First to Use Germany's New Confidential Pricing for Mounjaro (Insider Monkey)
03:01PM	Eli Lilly (LLY) Stock Trades Up, Here Is Why (StockStory)
02:30PM	Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst (Benzinga)
02:16PM	3 Unusual Insider Transactions you Should Know About (Zacks)
01:48PM	Eli Lilly Fires Up GLP-1 Race in India With Mounjaro Pen Launch (GuruFocus.com)
12:17PM	Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks? (Zacks)
11:30AM	Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs (Pharmaceutical Technology)
10:55AM	LLY: Eli Lilly Stock Tanks -- Insiders Rush In With Millions (GuruFocus.com)
10:47AM	Novo Nordisk Rises 6% So Far in August: How to Play the Stock (Zacks)
09:33AM	Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB (GlobeNewswire)
08:15AM	Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound (Benzinga)
04:10AM	The 3 Things That Matter for Viking Therapeutics Now (Motley Fool)
03:40AM	Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry (Reuters)
Aug-12-25 07:08PM	Analyst Report: Incyte Corporation (Morningstar Research)
07:07PM	These Eli Lilly executives have been scooping up stock after its big drop (MarketWatch)
06:15PM	Lilly CEO Buys $1 Million of Stock After Share-Price Drop on Obesity Drug Data (Barrons.com)
01:37PM	Eli Lilly and GSK drive South Koreas drug licensing activity (Pharmaceutical Technology)
01:24PM	Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications (Reuters)
11:10AM	The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly (Zacks)
09:45AM	1 Reason to Buy Eli Lilly (LLY) Stock (Motley Fool)
07:59AM	If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
05:32AM	US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche (GlobeNewswire)
03:26AM	LLY Q2 Deep Dive: Weight Loss Pill Data and Channel Dynamics Spur Investor Uncertainty (StockStory)
02:57AM	3 ways the GLP-1 market has changed shape this year (Pharma Voice)
02:57AM	Puerto Ricos ongoing journey from manufacturing hub to innovation enterprise (Pharma Voice)
Aug-11-25 08:49PM	Lightning Round: Get on board with Affirm, says Jim Cramer (CNBC TV)
08:18PM	Lilly's Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial (Insider Monkey)
06:01PM	PRIMECAP Management's Strategic Moves: Significant Reduction in Eli Lilly and Co (GuruFocus.com)
03:48PM	Why Eli Lilly Stock Popped Today (Motley Fool)
12:31PM	Why Eli Lilly (LLY) Stock Is Trading Up Today (StockStory)
12:25PM	Lilly first to opt for confidential reimbursement price in Germany (Pharmaceutical Technology)
11:57AM	3 Top Stocks to Load Up on After Earnings (Motley Fool)
10:23AM	Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval? (Zacks)
10:19AM	Eli Lilly (LLY) Announced Positive Results From its Phase 3 ATTAIN-1 Trial of Orforglipron (Insider Monkey)
09:15AM	Lilly (LLY) Reliance on International Sales: What Investors Need to Know (Zacks)
09:12AM	Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results? (Zacks)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM

Open in Screener

ADBE

Adobe Inc

Aug 18 • 04:00PM ET

357.24

Dollar change +2.39
Percentage change 0.67	%

Technology • Software - Application • USA • NASD

Peers: INTU ADSK CRM CDNS ANSS MSFT SNPS ORCL PANW EA

| Held by: VTI VOO QQQ IVV SPY VUG XLK VGT QUAL IWF

Index	NDX, S&P 500	P/E	22.84	EPS (ttm)	15.64	Insider Own	0.36%	Shs Outstand	427.00M	Perf Week	7.07%
Market Cap	151.54B	Forward P/E	15.43	EPS next Y	23.16	Insider Trans	0.05%	Shs Float	422.68M	Perf Month	-2.34%
Enterprise Value	152.39B	PEG	1.89	EPS next Q	5.18	Inst Own	84.13%	Short Float	2.46%	Perf Quarter	-14.36%
Income	6.87B	P/S	6.71	EPS this Y	11.84%	Inst Trans	-0.50%	Short Ratio	2.72	Perf Half Y	-22.37%
Sales	22.60B	P/B	13.32	EPS next Y	12.40%	ROA	23.64%	Short Interest	10.41M	Perf YTD	-19.66%
Book/sh	26.81	P/C	26.53	EPS next 5Y	12.09%	ROE	52.25%	52W High	587.75 -39.22%	Perf Year	-33.82%
Cash/sh	13.47	P/FCF	16.06	EPS past 3/5Y	7.24% 15.54%	ROIC	38.30%	52W Low	330.04 8.24%	Perf 3Y	-17.86%
Dividend Est.	-	EV/EBITDA	16.57	Sales past 3/5Y	10.85% 14.10%	Gross Margin	88.51%	Volatility	2.53% 2.17%	Perf 5Y	-17.92%
Dividend TTM	-	EV/Sales	6.74	EPS Y/Y TTM	40.10%	Oper. Margin	36.72%	ATR (14)	8.22	Perf 10Y	327.22%
Dividend Ex-Date	Mar 24, 2005	Quick Ratio	0.99	Sales Y/Y TTM	10.69%	Profit Margin	30.39%	RSI (14)	49.97	Recom	1.81
Dividend Gr. 3/5Y	- -	Current Ratio	0.99	EPS Q/Q	13.01%	SMA20	0.86%	Beta	1.49	Target Price	480.83
Payout	0.00%	Debt/Eq	0.57	Sales Q/Q	10.62%	SMA50	-4.01%	Rel Volume	0.76	Prev Close	354.85
Employees	30709	LT Debt/Eq	0.57	Earnings	Sep 10 AMC	SMA200	-14.61%	Avg Volume	3.82M	Price	357.24
IPO	Aug 13, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.75% 1.27%	Trades		Volume	2,919,012	Change	0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-25	Downgrade	Melius	Hold → Sell	$310
Jul-02-25	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$280
Apr-16-25	Reiterated	BMO Capital Markets	Outperform	$495 → $450
Apr-14-25	Reiterated	RBC Capital Mkts	Outperform	$530 → $480
Mar-21-25	Upgrade	KeyBanc Capital Markets	Underweight → Sector Weight
Mar-13-25	Reiterated	BMO Capital Markets	Outperform	$515 → $495
Feb-19-25	Initiated	Redburn Atlantic	Neutral
Jan-15-25	Upgrade	Exane BNP Paribas	Underperform → Neutral	$425
Jan-08-25	Downgrade	Deutsche Bank	Buy → Hold	$600 → $475
Dec-12-24	Downgrade	TD Cowen	Buy → Hold	$625 → $550
Dec-06-24	Reiterated	BMO Capital Markets	Outperform	$580 → $600
Sep-04-24	Reiterated	Oppenheimer	Outperform	$580 → $625
Jun-14-24	Upgrade	JP Morgan	Neutral → Overweight	$570 → $580
Jun-10-24	Downgrade	Melius	Buy → Hold	$510
Mar-21-24	Initiated	KeyBanc Capital Markets	Underweight	$445
Jan-18-24	Downgrade	Exane BNP Paribas	Neutral → Underperform	$499
Dec-18-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-08-23	Reiterated	BMO Capital Markets	Outperform	$670 → $690
Oct-26-23	Upgrade	Oppenheimer	Perform → Outperform	$660
Oct-26-23	Upgrade	DA Davidson	Neutral → Buy	$500 → $640

Show Previous Ratings

Aug-18-25 11:15PM	Melius Research Downgrades Adobe (ADBE) to Sell (Insider Monkey)
Aug-17-25 12:31PM	Coca-Cola, Amazon, Google, And Nvidia Have Used This Startup's AI Avatars Inside Jeff Lu's $40M Rise To America's Fastest-Growing Company (Benzinga)
02:17AM	Melius Research Downgrades Adobe Inc. (ADBE) to 'Sell' With $310 PT (Insider Monkey)
Aug-16-25 07:30AM	The old software investing playbook is dead. Here's where to put your money now. (MarketWatch)
Aug-15-25 09:30AM	Wall Street Analysts Think Adobe (ADBE) Is a Good Investment: Is It? (Zacks)
09:00AM	Loading…
09:00AM	Here is What to Know Beyond Why Adobe Inc. (ADBE) is a Trending Stock (Zacks)
12:33AM	Analysis-Powerful new AI models knock the wind out of European adopter stocks (Reuters)
Aug-14-25 03:11PM	Adtelligent Scoops Best Overall OTT Solution Provider" at 2025 MarTech Breakthrough Awards (GlobeNewswire)
11:34AM	4 Buy-the-Dip Stocks Ready to Bounce Back (Motley Fool)
10:15AM	CDNS, NVDA Team Up to Advance Billion-Gate AI Design Power Analysis (Zacks)
10:05AM	Anoki Named "Best Overall CTV Solution Provider" in 2025 MarTech Breakthrough Awards (Business Wire)
09:30AM	Cloud Computing Market Surges to $2,281.1 billion by 2030 - Dominated by Microsoft (US), Google (US), IBM (US) (GlobeNewswire)
Aug-13-25 05:20PM	Adobe, Bill.com, Atlassian, Bandwidth, and Wix Shares Skyrocket, What You Need To Know (StockStory)
10:58AM	After Hitting 30th 52-Week Low, Is Adobe Too Cheap to Ignore? (Barchart)
10:02AM	AI/R Company Subsidiary, WEBJUMP, Launches AI-powered Component Library to Accelerate Adobe AEM Implementations (GlobeNewswire)
10:00AM	Loading…
10:00AM	AI in Education Market Surges to $5.82 billion by 2030 - Dominated by Microsoft (US), IBM (US), Google (US) (GlobeNewswire)
07:46AM	5 Stocks to Buy on S&P 500's 16th Record Closing High of the Year (Zacks)
06:30AM	Is There Life After AI for Big Software? (The Daily Upside)
Aug-12-25 05:45PM	Adobe Systems (ADBE) Rises Higher Than Market: Key Facts (Zacks)
12:23PM	Adobe Drops 9% in a Month: Should You Buy the Dip in ADBE Stock? (Zacks)
10:48AM	Billions wiped out as software stocks sink on AI disruption fear (Bloomberg)
10:18AM	AKOOL Ranks #1 on Inc. Magazine's 2025 Inc. 5000 List (PR Newswire)
08:52AM	Software stocks in Europe fall on concerns over AI pitfalls (Reuters)
08:32AM	CoreWeave Stock Soars as JPMorgan Hikes Target Ahead of Earnings (GuruFocus.com)
03:40AM	Adobe Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Aug-11-25 05:21PM	Adobe Stock Downgraded As 'AI Is Eating Software' (Investor's Business Daily)
05:18PM	The tech sector hasn't been this top-heavy in decades. That could be an opportunity for investors hunting for bargains. (MarketWatch)
02:48PM	Calls of the Day: TKO Group, Adobe (CNBC TV)
01:49PM	AI is eating software, and Adobe is on the menu. Why the stock could be in trouble. (MarketWatch)
12:42PM	Adobe Stock Gets a Downgrade. AI Is Eating Software, Analyst Says. (Barrons.com)
11:11AM	Loading…
11:11AM	Melius Research warns that things can get worse for SaaS players like Adobe (Investing.com)
09:49AM	If You Missed Adobe or Canva, Watch This Stock Now (Motley Fool)
09:33AM	Arm initiated, Adobe downgraded: Wall Street's top analyst calls (The Fly)
05:41AM	These 3 Artificial Intelligence (AI) Stocks Could Soar More Than 40% Over the Next 12 Months, According to Wall Street (Motley Fool)
12:30AM	AI Won't Kill Software. It Will Simply Give It New Life. (Barrons.com)
Aug-10-25 03:36PM	Bringing AI To Fashion: These Startups Are Changing How We Approach Personal Style And Cutting Costs For Retailers (Benzinga)
12:05AM	Goldman Sachs Reiterates its Buy Rating on Adobe, Keeps PT at $570 (Insider Monkey)
Aug-09-25 09:00AM	Traders Are Fleeing Stocks Feared to Be Under Threat From AI (Bloomberg)
Aug-08-25 08:31PM	I Tried To Buy 1,000 Shares Of The Figma IPO...Here's What Happened (Benzinga)
03:57PM	Figmas $21 Billion Drop Returns Stock to Earth After IPO Frenzy (Bloomberg)
Aug-07-25 04:03PM	Akamai raises annual results forecast on cybersecurity demand (Reuters)
12:39PM	Morgan Stanley Maintained a Buy Rating on Adobe (ADBE), Noting it As Undervalued Relative to the Growth Potential (Insider Monkey)
12:37PM	Youre welcome': Biden's antitrust chief points to Figma IPO as vindication of his policy (Semafor)
12:37PM	Youre welcome: Jonathan Kanter on Figma's IPO and Trump antitrust (Semafor)
09:45AM	Here's Why Adobe Systems (ADBE) is a Strong Growth Stock (Zacks)
09:03AM	Cavallo Expands SalesPad eCommerce Capabilities to Strengthen Omnichannel Distribution Support (PR Newswire)
Aug-06-25 05:45PM	Adobe Systems (ADBE) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
04:53PM	Retail Stocks Jumped. Thank Shopify's Earnings. (Barrons.com)
10:54AM	Figma at 300x Earnings: Bubble Hype or the Next Great Compounder? (GuruFocus.com)
07:55AM	Block Party and Big Swings (Motley Fool)
07:33AM	Morgan Stanley Reiterates Bullish $510 Target on Adobe (ADBE) Amid GenAI Momentum (Insider Monkey)
04:57AM	Palantir Is Now a $400 Billion-Plus Company (The Wall Street Journal)
Aug-05-25 11:49AM	Palantir's stock heads for a market-cap milestone just months after its last one (MarketWatch)
11:00AM	Buying Adobe Over Figma Could Be the Smart Move for Investors (Motley Fool)
10:34AM	AI for Sales and Marketing Company Evaluation Report 2025 \| Salesforce, Google, and Adobe Lead with Advanced Personalization, Predictive Analytics, and Marketing Automation (GlobeNewswire)
10:12AM	Figma's Wild IPO Ride: Is the Stock's Premium Price Justified? (MarketBeat)
09:15AM	Cathie Wood is Buying Figma Stock with Both Hands. Should You Buy This Hot IPO, Too? (Barchart)
09:12AM	Europe Online Education Market Trends and Company Analysis Report 2025-2033 Featuring Coursera, Instructure, Adobe, Alphabet, Udemy, Pearsons, Stride, NetEase (GlobeNewswire)
Aug-04-25 01:10PM	Figma sheds $11 billion in market value days after blockbuster IPO (Reuters)
09:00AM	Adobe Inc. (ADBE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:30AM	AI Adoption May Reprice Adobe, Amazon, Johnson Controls (GuruFocus.com)
05:26AM	The Zacks Analyst Blog Highlights Adobe, Disney, Intuit, Rollins and Johnson & Johnson (Zacks)
Aug-02-25 04:58PM	Lina Khan points to Figma IPO as vindication of M&A scrutiny (TechCrunch)
Aug-01-25 02:47PM	Investors Are Flocking to Figma. Why Is the Design Software Maker's Stock So Hot? (Investopedia)
02:15PM	Figmas 33-year-old cofounder is a former LinkedIn intern who launched the $68 billion Wall Street darling with $100k from Peter Thiel (Fortune)
11:10AM	Adobes Failed Acquisition of Figma Has Cost the Company Over $38 Billion and Counting Heres How High It Could Go (Barchart)
10:22AM	Figma Stock Rises After Record IPO Surge. Cathie Wood Bought in, There's a Hurdle for Others. (Barrons.com)
10:05AM	Figma's blockbuster IPO could fuel wave of new listings (Yahoo Finance Video)
09:00AM	AI/R Accelerates Personalization at Scale Through Webjumps Latest Adobe Milestone (GlobeNewswire)
08:58AM	Figma stock wavers after blockbuster 250% debut rally (Yahoo Finance)
08:58AM	Figma stock rises 19% in premarket trade Friday, poised to build on Thursday's 250% rally (Yahoo Finance)
08:58AM	Figma stock gains 5% after blockbuster 250% debut rally (Yahoo Finance)
07:15AM	Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns (Zacks)
06:45AM	Design software maker Figma extends gains after blockbuster NYSE trading debut (Reuters)
06:30AM	Barnburner Figma IPO Offers Good Omen as Klarna Reconsiders Debut (The Daily Upside)
Jul-31-25 09:33PM	Figma stock skyrockets 198% in explosive NYSE debut (TheStreet)
07:07PM	How Figma Made Design Everyones Business (The Wall Street Journal)
06:36PM	Figmas 250% IPO Pop Gives It Edge in Creative AI Software Fight (Bloomberg)
06:10PM	Is Figma a Buy After Tripling on Its IPO? (Motley Fool)
05:01PM	Iconiqs Will Griffith explains how his firm celebrated Figmas IPO and why investors sold shares (TechCrunch)
04:42PM	Figma stock soars 250% in first day of trading, valuing company north of $45 billion (Yahoo Finance)
04:33PM	Figma Stock Pops 250% in Trading Debut (Barrons.com)
04:25PM	Figma Stock Blasts Off With Well-Received IPO (Investor's Business Daily)
04:10PM	Software Maker Figma Surges 250% in Debut After $1.2 Billion IPO (Bloomberg)
03:38PM	Figma Stock More Than Triples on Its First Day of Trading (Investopedia)
02:44PM	Figma shares more than triple in soaring public debut (Fortune)
02:18PM	Tech Darling Figma Soars 198% Following IPO; Holds $70M in Bitcoin ETF (CoinDesk)
02:15PM	Figmas stock soars in its highly anticipated IPO, market cap instantly hits $45B (TechCrunch)
02:09PM	Figma Stock Pops More Than 200% in Trading Debut (Barrons.com)
01:05PM	Figma Stock Set to Triple When It Starts Trading Today (Barrons.com)
12:08PM	Microsoft Q4 Earnings & Revenues Beat on Cloud Business Expansion (Zacks)
12:06PM	Shake Shack, AB InBev, Figma: Trending Tickers (Yahoo Finance Video)
11:51AM	Figma Prices IPO at $33 a Share, Valuing It at $19.3 Billion. The Stock Starts Trading Today. (Barrons.com)
10:08AM	AI/R Accelerates Personalization at Scale Through Webjumps Latest Adobe Milestone (GlobeNewswire)
09:52AM	VC-Backed Figma IPO Will Be Big. Will It Spark Rush To IPOs? (Investor's Business Daily)
09:22AM	Figma stock set for debut after IPO prices at $33 per share (Yahoo Finance)
09:22AM	Figma stock opens for trade at $85, up 158% from where IPO priced (Yahoo Finance)
09:05AM	Top Wide-Moat Stocks to Buy for Long-Term Wealth and Stability (Zacks)
07:44AM	As Figma goes public, a turning point in the long-awaited IPO market recovery takes shape (Fortune)
06:42AM	Design software maker Figma's shares set to double in blowout market debut (Reuters)

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NARAYEN SHANTANU	Chair and CEO	Jul 24 '25	Option Exercise	0.00	1,254	0	389,796	Jul 28 05:07 PM
Wadhwani David	President, Digital Media	Jul 24 '25	Option Exercise	0.00	606	0	25,138	Jul 28 05:07 PM
Durn Daniel	EVP & CFO	Jul 24 '25	Option Exercise	0.00	606	0	33,530	Jul 28 05:06 PM
Chen Gloria	EVP, Chief People Officer	Jul 24 '25	Option Exercise	0.00	424	0	39,282	Jul 28 05:06 PM
Chakravarthy Anil	President, DX	Jul 24 '25	Option Exercise	0.00	606	0	44,666	Jul 28 05:05 PM
Forusz Jillian	SVP & CAO	Jul 24 '25	Option Exercise	0.00	30	0	3,279	Jul 28 04:39 PM
Chakravarthy Anil	President, DX	Jul 15 '25	Option Exercise	0.00	1,894	0	44,405	Jul 17 04:50 PM
Chen Gloria	EVP, Chief People Officer	Jul 15 '25	Option Exercise	0.00	1,938	0	39,217	Jul 17 04:48 PM
Durn Daniel	EVP & CFO	Jul 15 '25	Option Exercise	0.00	2,833	0	33,474	Jul 17 04:47 PM
Wadhwani David	President, Digital Media	Jul 15 '25	Option Exercise	0.00	1,894	0	24,877	Jul 17 04:45 PM
NARAYEN SHANTANU	Chair and CEO	Jul 15 '25	Option Exercise	0.00	5,443	0	389,522	Jul 17 04:43 PM
Forusz Jillian	SVP & CAO	Jul 15 '25	Option Exercise	0.00	117	0	3,259	Jul 17 04:41 PM
Wadhwani David	President, Digital Media	Jun 14 '25	Option Exercise	0.00	1,933	0	24,477	Jun 16 05:48 PM
Forusz Jillian	SVP & CAO	Jun 15 '25	Option Exercise	0.00	460	0	3,214	Jun 16 05:48 PM
Forusz Jillian	SVP & CAO	May 02 '25	Sale	380.58	462	175,828	2,834	May 06 04:14 PM
Forusz Jillian	Officer	May 02 '25	Proposed Sale	380.58	462	175,828		May 02 04:31 PM
Chakravarthy Anil	President, DX	Apr 24 '25	Option Exercise	0.00	606	0	43,347	Apr 28 04:35 PM
Durn Daniel	EVP & CFO	Apr 24 '25	Option Exercise	0.00	606	0	31,833	Apr 28 04:29 PM
Forusz Jillian	SVP & CAO	Apr 24 '25	Option Exercise	0.00	30	0	3,306	Apr 28 04:29 PM
NARAYEN SHANTANU	Chair and CEO	Apr 24 '25	Option Exercise	0.00	1,254	0	386,417	Apr 28 04:29 PM
Wadhwani David	President, Digital Media	Apr 24 '25	Option Exercise	0.00	606	0	22,844	Apr 28 04:28 PM
Chen Gloria	EVP, Chief People Officer	Apr 24 '25	Option Exercise	0.00	424	0	38,032	Apr 28 04:28 PM
AMON CRISTIANO R	Director	Apr 22 '25	Option Exercise	0.00	633	0	922	Apr 23 06:56 PM
Banse Amy	Director	Apr 22 '25	Option Exercise	0.00	633	0	33,562	Apr 23 06:56 PM
Boulden Melanie	Director	Apr 22 '25	Option Exercise	0.00	633	0	3,065	Apr 23 06:55 PM
CALDERONI FRANK	Director	Apr 22 '25	Option Exercise	0.00	633	0	31,817	Apr 23 06:55 PM
Neumann Spencer Adam	Director	Apr 22 '25	Option Exercise	0.00	633	0	2,278	Apr 23 06:55 PM
Oberg Kathleen K.	Director	Apr 22 '25	Option Exercise	0.00	633	0	4,350	Apr 23 06:55 PM
Pandey Dheeraj	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,020	Apr 23 06:55 PM
ROSENSWEIG DANIEL	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,006	Apr 23 06:55 PM
Ricks David A	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,617	Apr 23 06:54 PM
Desmond Laura	Director	Apr 22 '25	Option Exercise	0.00	633	0	31,733	Apr 23 06:54 PM
Biggs M. Brett	Director	Apr 22 '25	Option Exercise	0.00	633	0	2,278	Apr 23 06:54 PM
Wadhwani David	President, Digital Media	Apr 15 '25	Option Exercise	0.00	1,892	0	22,582	Apr 17 07:30 PM
NARAYEN SHANTANU	Chair and CEO	Apr 15 '25	Option Exercise	0.00	5,440	0	386,143	Apr 17 07:30 PM
Forusz Jillian	SVP & CAO	Apr 15 '25	Option Exercise	0.00	114	0	3,283	Apr 17 07:29 PM
Durn Daniel	EVP & CFO	Apr 15 '25	Option Exercise	0.00	2,832	0	31,776	Apr 17 07:29 PM
Chen Gloria	EVP, Chief People Officer	Apr 15 '25	Option Exercise	0.00	1,935	0	37,966	Apr 17 07:29 PM
Chakravarthy Anil	President, DX	Apr 15 '25	Option Exercise	0.00	1,892	0	43,085	Apr 17 07:28 PM
Belsky Scott	Officer	Apr 01 '25	Proposed Sale	383.00	5,012	1,919,596		Apr 01 05:37 PM
Durn Daniel	EVP & CFO	Mar 20 '25	Buy	390.58	1,300	507,758	29,876	Mar 21 04:34 PM
Forusz Jillian	SVP & CAO	Mar 15 '25	Option Exercise	0.00	785	0	3,278	Mar 17 05:57 PM
Wadhwani David	President, Digital Media	Mar 14 '25	Option Exercise	0.00	1,933	0	22,240	Mar 17 05:57 PM
Ricks David A	Director	Jan 28 '25	Buy	443.98	2,250	998,946	4,984	Jan 30 07:45 PM
Forusz Jillian	Officer	Jan 28 '25	Proposed Sale	435.83	334	145,567		Jan 28 05:01 PM
Chen Gloria	EVP, Chief People Officer	Jan 24 '25	Option Exercise	0.00	6,186	0	38,697	Jan 28 04:59 PM
Durn Daniel	EVP & CFO	Jan 24 '25	Option Exercise	0.00	8,262	0	32,294	Jan 28 04:59 PM
NARAYEN SHANTANU	Chair and CEO	Jan 24 '25	Option Exercise	0.00	39,548	0	399,463	Jan 28 04:58 PM
Chakravarthy Anil	President, DX	Jan 24 '25	Option Exercise	0.00	8,866	0	44,968	Jan 28 04:58 PM
Belsky Scott	Chief Strategy Officer & EVP	Jan 24 '25	Option Exercise	0.00	8,732	0	26,706	Jan 28 04:58 PM
Belsky Scott	Chief Strategy Officer & EVP	Jan 27 '25	Sale	430.24	3,819	1,643,087	18,334	Jan 28 04:58 PM
Belsky Scott	Chief Strategy Officer & EVP	Jan 24 '25	Sale	437.28	922	403,172	22,153	Jan 28 04:58 PM
Wadhwani David	President, Digital Media	Jan 24 '25	Option Exercise	0.00	8,262	0	23,622	Jan 28 04:58 PM
Forusz Jillian	SVP & CAO	Jan 24 '25	Option Exercise	0.00	442	0	3,122	Jan 28 04:58 PM
Forusz Jillian	SVP & CAO	Jan 28 '25	Sale	435.83	334	145,567	2,685	Jan 28 04:58 PM
SCOTT K BELSKY	Officer	Jan 27 '25	Proposed Sale	430.24	3,819	1,643,087		Jan 27 04:17 PM
SCOTT K BELSKY	Officer	Jan 24 '25	Proposed Sale	437.28	922	403,172		Jan 24 04:02 PM
NARAYEN SHANTANU	Chair and CEO	Jan 15 '25	Option Exercise	0.00	3,465	0	363,103	Jan 17 04:46 PM
Belsky Scott	Chief Strategy Officer & EVP	Jan 15 '25	Option Exercise	0.00	1,568	0	19,280	Jan 17 04:45 PM
Chakravarthy Anil	President, DX	Jan 15 '25	Option Exercise	0.00	1,197	0	37,528	Jan 17 04:45 PM
Chen Gloria	EVP, Chief People Officer	Jan 15 '25	Option Exercise	0.00	1,212	0	33,490	Jan 17 04:45 PM
Durn Daniel	EVP & CFO	Jan 15 '25	Option Exercise	0.00	1,783	0	24,978	Jan 17 04:45 PM
Forusz Jillian	SVP & CAO	Jan 15 '25	Option Exercise	0.00	94	0	2,755	Jan 17 04:44 PM
Wadhwani David	President, Digital Media	Jan 15 '25	Option Exercise	0.00	1,197	0	16,117	Jan 17 04:44 PM
Forusz Jillian	SVP & CAO	Dec 15 '24	Option Exercise	0.00	782	0	3,022	Dec 17 05:16 PM
Wadhwani David	President, Digital Media	Dec 14 '24	Option Exercise	0.00	1,933	0	16,159	Dec 17 05:16 PM
Banse Amy	Director	Dec 06 '24	Sale	550.00	606	333,300	32,929	Dec 10 04:01 PM
AMY BANSE	Director	Dec 06 '24	Proposed Sale	538.22	606	326,161		Dec 06 04:32 PM
Rao Dana	Officer	Nov 26 '24	Proposed Sale	522.05	8,671	4,526,692		Nov 26 07:31 PM
Durn Daniel	EVP & CFO	Nov 15 '24	Option Exercise	0.00	3,837	0	25,813	Nov 19 06:24 PM
Forusz Jillian	SVP & CAO	Oct 29 '24	Sale	484.97	676	327,987	2,715	Oct 31 05:16 PM
Rao Dana	Officer	Oct 30 '24	Proposed Sale	491.10	4,013	1,970,765		Oct 30 04:24 PM
Forusz Jillian	Officer	Oct 29 '24	Proposed Sale	484.97	676	327,843		Oct 29 06:51 PM
Chakravarthy Anil	President, DX	Oct 24 '24	Option Exercise	0.00	1,208	0	37,025	Oct 28 05:13 PM
Chen Gloria	EVP, Chief People Officer	Oct 24 '24	Option Exercise	0.00	826	0	32,774	Oct 28 05:13 PM
Durn Daniel	EVP & CFO	Oct 24 '24	Option Exercise	0.00	605	0	22,292	Oct 28 05:13 PM
Forusz Jillian	SVP & CAO	Oct 24 '24	Option Exercise	0.00	60	0	3,406	Oct 28 05:13 PM
NARAYEN SHANTANU	Chair and CEO	Oct 24 '24	Option Exercise	0.00	2,561	0	361,361	Oct 28 05:13 PM
Wadhwani David	President, Digital Media	Oct 24 '24	Option Exercise	0.00	605	0	14,525	Oct 28 05:12 PM
Belsky Scott	Chief Strategy Officer & EVP	Oct 24 '24	Option Exercise	0.00	1,074	0	18,943	Oct 28 05:12 PM
Belsky Scott	Chief Strategy Officer & EVP	Oct 25 '24	Sale	483.42	481	232,525	18,128	Oct 28 05:12 PM
SCOTT K BELSKY	Officer	Oct 25 '24	Proposed Sale	483.42	481	232,525		Oct 25 04:13 PM
Chen Gloria	EVP, Chief People Officer	Oct 15 '24	Option Exercise	0.00	1,212	0	32,366	Oct 17 05:48 PM
Durn Daniel	EVP & CFO	Oct 15 '24	Option Exercise	0.00	1,781	0	22,027	Oct 17 05:48 PM
Forusz Jillian	SVP & CAO	Oct 15 '24	Option Exercise	0.00	95	0	3,377	Oct 17 05:48 PM
NARAYEN SHANTANU	Chair and CEO	Oct 15 '24	Option Exercise	0.00	3,464	0	360,074	Oct 17 05:48 PM
Wadhwani David	President, Digital Media	Oct 15 '24	Option Exercise	0.00	1,198	0	14,136	Oct 17 05:48 PM
Chakravarthy Anil	President, DX	Oct 15 '24	Option Exercise	0.00	1,198	0	36,331	Oct 17 05:47 PM
Belsky Scott	Chief Strategy Officer & EVP	Oct 15 '24	Option Exercise	0.00	1,569	0	20,677	Oct 17 05:47 PM
Belsky Scott	Chief Strategy Officer & EVP	Oct 15 '24	Sale	513.82	1,530	786,145	18,831	Oct 17 05:47 PM
Belsky Scott	Chief Strategy Officer & EVP	Oct 16 '24	Sale	506.39	703	355,992	18,128	Oct 17 05:47 PM
SCOTT K BELSKY	Officer	Oct 16 '24	Proposed Sale	506.39	703	355,992		Oct 16 04:18 PM
SCOTT K BELSKY	Officer	Oct 15 '24	Proposed Sale	513.82	1,530	786,145		Oct 15 04:31 PM
NARAYEN SHANTANU	Chair and CEO	Sep 25 '24	Sale	521.58	25,000	13,039,414	357,700	Sep 26 04:21 PM
Narayen Family Trust	Officer	Sep 25 '24	Proposed Sale	521.58	25,000	13,039,400		Sep 25 03:19 PM
Rao Dana	Officer	Sep 19 '24	Proposed Sale	520.61	3,220	1,676,354		Sep 19 04:54 PM
Durn Daniel	EVP & CFO	Sep 17 '24	Sale	515.44	6,500	3,350,328	20,838	Sep 19 04:28 PM
Wadhwani David	President, Digital Media	Sep 14 '24	Option Exercise	0.00	1,932	0	14,272	Sep 17 05:54 PM
Forusz Jillian	SVP & CAO	Sep 15 '24	Option Exercise	0.00	556	0	3,426	Sep 17 05:54 PM
Durn Daniel	Officer	Sep 17 '24	Proposed Sale	530.00	6,500	3,445,000		Sep 17 04:24 PM

LLY

Lilly(Eli) & Co

ADBE

Adobe Inc

Upgrade your FINVIZ experience